Search results for

The act of using a registered trade mark for the designated goods of that registered trade mark usually constitutes an act of infringement when performed by a third party with no direct rights thereto. Such acts are naturally subject to injunction and damage compensation. However, the case is not so clear-cut in the situation where the third party is importing trade marked goods which are genuine articles manufactured by one having the right to use the trade mark and legitimately purchased in another country (so-called parallel importation). In 1970, the Osaka District Court made it clear that parallel importation of trade marked goods may, in some circumstances, not constitute infringement. Similar decisions have since been issued by other lower courts.

The island of Puerto Rico has failed to convince a WIPO panel it should have the rights to the disputed domain name puertorico.com.

San Diego biotech company Diversa Corporation is the most innovative company in the world, according to a new study.

Optional searching could be the compromise to break the deadlock over the issue of national searches, the head of Europe's trade mark office has suggested.

The Hatch-Waxman Act in the US represented a careful balance of interests between the generic and brand name pharmaceutical manufacturers. William Feiler and Paula Wittmayer examine the Safe Harbor exemption and the challenges it represents to the biotech industry

The GSM story is one of success for the market as well as investors in the technology and IP rights holders, and it will be for the market to resolve the forthcoming issues on 3G IP rights by tried and tested methods, argues Hugh Dunlop

Survival and success for biotech companies across the US and worldwide is a tenuous and arduous endeavor in today's economy. Robin Silva offers some tips on how to ride the wave successfully

On February 28 2003 the Singapore government introduced a number of fiscal incentives in the 2003 budget to make Singapore an even more attractive location for IP rights holders.

On April 10, the European Parliament, in its first reading of the Tissues and Cells Directive (the Directive), voted in favour of a ban on the creation of human embryos for research purposes including stem cell research. MEPs stopped short of demanding an outright ban on the use of embryonic stem (ES) cells for research. However, they imposed severe restrictions, the effect of which could be to make it difficult for scientists to justify their use.

? Italy: The country has joined Greece and Denmark in implementing the EU copyright directive into its national law - with most other EU member states facing the prospect of being taken to the European Court of Justice.